This award engages cross-disciplinary investigators to drive collaborative retinal degenerative disease research efforts. The PPA enables studies that are too large or technically complex for a single investigator to undertake in a reasonable amount of time and to address current knowledge and/or therapeutic gaps. The effort is unified around a single, well-articulated research hypothesis and clearly defined milestones relevant to the Foundation’s mission. The PPA award address knowledge gaps or therapeutic goals identified by The Foundation or an equally significant gap or goal approved by the Foundation. Funding for this effort will be considered up to $500,000 per year up to five (5) years.
Requests for Applications will be by invitation only. For additional information, send an email request to email@example.com.
Research progress and accomplishments are tracked during the funding period through Scientific Progress and Financial reports. All reports should be uploaded to the Foundation’s reporting portal.
The urgent mission of the Foundation Fighting Blindness is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, age-related macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases. The Foundation is a beacon for those affected by these blinding diseases. Join the fight and help us accelerate our mission.
Welcome to the new Foundation site — supported in partnership with Genentech, A Member of the Roche Group.
FFB meets all 20 Better Business Bureau Charity Standards.